Trials / Completed
CompletedNCT01136317
Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study aims to determine, in obese subjects, the antisecretory effect of a single dose of placebo, rabeprazole 20 mg and omeprazole 20 mg using 24h gastric pH monitoring, in a prospective, monocentre, randomized manner. Monitorings are separated between 6 and10 days. The main outcome criteria of analysis is the percentage of time with gastric pH above 3 during 24hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omeprazole | |
| DRUG | Rabeprazole | |
| DRUG | Lactose |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-06-03
- Last updated
- 2010-09-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01136317. Inclusion in this directory is not an endorsement.